Nadolol Tablet
FDA Label NDC 70771-1091

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Nadolol (NDC 70771-1091). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1089-9

Nadolol tablets, 20 mg

Rx only

90 tablets

Nadolol Tablets (A8d6ae8b D94a 46a9 89a8 867e1c9e65a2 02)

NDC 70771-1090-9

Nadolol tablets, 40 mg

Rx only

90 tablets

Nadolol Tablets (A8d6ae8b D94a 46a9 89a8 867e1c9e65a2 03)

NDC 70771-1091-9

Nadolol tablets, 80 mg

Rx only

80 tablets

Nadolol Tablets (A8d6ae8b D94a 46a9 89a8 867e1c9e65a2 04)

* Please review the disclaimer below.